Lanean...
Venetoclax: a real game changer in treatment of chronic lymphocytic leukemia
Venetoclax – a novel, orally bioavailable inhibitor of B-cell lymphoma-2 – has demonstrated substantial clinical activity in the treatment of chronic lymphocytic leukemia. Alone or in combination with other targeted agents, venetoclax results in high rate of durable responses and undetectable measur...
Gorde:
| Argitaratua izan da: | Int J Hematol Oncol |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Future Medicine Ltd
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7689538/ https://ncbi.nlm.nih.gov/pubmed/33294171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2020-0010 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|